Viewing Study NCT00005951


Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2025-12-25 @ 9:37 PM
Study NCT ID: NCT00005951
Status: COMPLETED
Last Update Posted: 2014-08-22
First Post: 2000-07-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma
Sponsor: Duke University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module